Wen Zhou
Chen Xie
Quli Fan- State Key Laboratory for Organic Electronics and Information Displays & Institute of Advanced Materials IAM, Nanjing University of Posts & Telecommunications, Nanjing, China
Photoacoustic (PA) imaging in the second near-infrared (NIR-II) window has gained more and more attention in recent years and showed great potential in the field of bioimaging. Until now, numerous materials have been developed as contrast agents for NIR-II PA imaging. Among them, small molecule dyes hold unique advantages such as definite structures and capability of fast clearance from body. By virtue of these advantages, small molecule dyes-constructed nanoparticles have relatively small size and show promise in the clinical translation. Thus, in this minireview, we summarize recent advances in small molecule dyes-based nanotheranostics for NIR-II PA imaging and cancer therapy. Studies about NIR-II PA imaging-guided phototherapy are first introduced. Then, NIR-II PA imaging-guided phototherapy-based combination therapeutic systems are reviewed. Finally, the conclusion and perspectives of this field are summarized and discussed.
1 Introduction
Photoacoustic (PA) imaging is a kind of optical imaging modality which utilizes light as the excitation source and collect ultrasound waves as the signal source (Attia et al., 2019; Yang et al., 2009). By virtue of such feature, PA imaging has both higher tissue penetration depth and spatial resolution (Hoelen et al., 1998; Wang and Hu, 2012). Until now, PA imaging has been applied for clinical detection of breast cancer, and shows a higher sensitivity than conventional ultrasound imaging (Valluru and Willmann, 2016). In addition, PA imaging can be facilely combined with ultrasound imaging to develop multimodal imaging modality as they both detect acoustic waves (Manwar et al., 2020). Although the great potential of PA imaging, only a few endogenous biomasses such as hemoglobin and deoxyhemoglobin show PA signals under laser irradiation, making it necessary to develop exogenous contrast agents for PA imaging to achieve a better imaging effect (Cheng et al., 2020; Cui et al., 2019; Huang and Pu, 2020; Weber et al., 2016).
Until now, variety of materials have been designed as PA contrast agents. For example, inorganic nanomaterials including gold nanoparticles (Kim et al., 2018; Mallidi et al., 2009), quantum dots (Guo et al., 2021; Lv et al., 2016), 2D materials (Yu et al., 2019) have been widely applied for PA imaging-related biomedical applications owing to their broad absorption spectra and high photothermal conversion efficiency (PCE). Apart from inorganic nanomaterials, organic materials have attracted more and more attention in phototheranostics (Zhang et al., 2022; Zhang et al., 2021). Two major kinds of organic materials, semiconducting polymers (SPs) and small molecule dyes, can both be developed into PA contrast agents (Chen et al., 2019; He et al., 2020a; Li et al., 2020; Xu and Pu, 2021; Zhang et al., 2019a). Owing to the advantages of high absorption coefficient and good photostability, SPs usually exhibit satisfactory PA signals (Pu et al., 2014; Sun et al., 2018; Chen et al., 2020a; Zhen et al., 2021). However, because of their high molecular weight, SPs are hardly cleared from body in a relatively short time, which may cause long-term toxicity (Gupta et al., 2021). In contrast, small molecule dyes have much lower molecular weights with definite structures. Such feature endows them with possibility of fast clearance from body, which shows great promise in clinical translation (Huang et al., 2019a; Zhen et al., 2018). For example, indocyanine green (ICG) has been approved by FDA as optical imaging contrast agent for human body (He et al., 2020b; Soni et al., 2016). However, the photostability of ICG and its derivatives are poor, limiting their further applications (Noh et al., 2011). Thus, designing novel small molecule dyes as PA contrast agents is of great significance.
Although PA imaging has a relatively deep tissue penetration among all the optical imaging modalities, the penetration depth is still restricted compared with traditional modalities such as CT and MRI (Penet et al., 2010; Zhou et al., 2020). Most PA imaging-based theranostics utilize first near-infrared window (NIR-I, 700–900 nm) light as excitation source. Compared with NIR-I light, second near-infrared window (NIR-II, 1,000–1700 nm) light shows both lower tissue absorption and scattering, resulting in a higher tissue penetration depth (Chen et al., 2020b; Zhao et al., 2018). Thus, using NIR-II light as excitation source of PA imaging can achieve a better tissue penetration and imaging effect. Compared with NIR-I PA contrast agents, NIR-II PA contrast agents have longer absorption wavelengths (Miao and Pu, 2018; Yin et al., 2021a). Until now, variety of inorganic and SPs-based nanomaterials have been reported for NIR-II PA imaging and phototheranostics (Cao et al., 2018; Jiang et al., 2019; Wu et al., 2017; Zhang et al., 2019b). However, for small molecule dyes, NIR-II absorbing molecules usually have larger π-conjugated backbones and more complicated structures than NIR-I absorbing molecules, which makes it more difficult to be synthesized (Antaris et al., 2016; Li et al., 2022; Wang et al., 2019).
By virtue of the great potential of NIR-II PA imaging, several excellent reviews have summarized the progress in this field (Zhen et al., 2021; Yin et al., 2021a; Li et al., 2022; Upputuri and Pramanik, 2019; Huang et al., 2019b). However, most of them focused on the PA imaging systems or contrast agents such as inorganic nanomaterials or semiconducting polymer nanoparticles (SPNs). Inspired by the significant advantages of small molecule dyes, we summarize recent advances of small molecule dyes in NIR-II PA imaging-related phototheranostics in this minireview. In the following, we first introduce the design and classification of NIR-II PA contrast agents. Then, the application of small molecule dyes for NIR-II PA imaging-guided phototheranostics and combination therapy are sequentially discussed. Finally, the conclusion and future perspectives of this field are given.
2 Design and classification of NIR-II PA contrast agents
The reported small molecule-based NIR-II PA contrast agents could be generally classified into three types: NIR-II-absorbing molecules, metal complexes and charge-transfer complexes. NIR-II-absorbing molecules were the most reported one for NIR-II PA imaging. Until now, several kinds of NIR-II-absorbing molecules were designed for NIR-II phototheranostics, such as donor-acceptor-donor (D-A-D) type oligomers, cyanine and boron-dipyrromethenes (BODIPY) derivatives (Yin et al., 2021b). Cyanine and BODIPY derivatives have been developed into NIR-II PA contrast agents, which introduced in the following sections, and almost all of them showed a red-shifted absorption after being encapsulated into nanoparticles. Such feature endowed them with unique advantages for NIR-II PA imaging. Metal complexes were prepared by chelating metal ions such as Fe and Cu with small molecule dyes (Chalati et al., 2011; Meng et al., 2015) Due to the ligand to metal charge transfer (LMCT) effect which was widely reported in metal organic frameworks (MOFs), metal complexes had very broad absorption which could tail to NIR-II region, although their maximum absorption may not locate in NIR-II region (Zhao et al., 2021). This made them suitable for NIR-II PA imaging. Charge transfer complexes were formed between electron-donating and electron-accepting molecules. The stronger donating or accepting molecules used, the molecules with longer absorption would obtain (Zhang et al., 2017). Charger transfer complexes may have a much longer absorption than other two kinds of small molecule-based NIR-II PA contrast agents (Table 1).
TABLE 1. Summary of small molecule-based contrast agents for NIR-II PA imaging.
All of these molecules or complexes mentioned had poor water solubility and required the addition of amphiphilic molecules to increase their solubility in water. F127 was the mostly chosen amphiphilic molecules, not only because its commercial availability and low cost, but also the feasibility of preparing high concentration nanoparticles via surfactant-stripped approach (Zhang et al., 2018). These molecules or complexes had satisfactory PCE (higher than 40%), making them good candidates for NIR-II PA imaging-guided photothermal therapy (PTT).
3 NIR-II PA imaging-guided phototheranostics
Phototheranostics which combine optical imaging and phototherapy into one system have attracted tremendous attention in recent years (Cai et al., 2018). However, most phototheranostic nanosystems utilize NIR-I light as the source for optical imaging and phototherapy (Li et al., 2018a; Wan et al., 2020) The low penetration depth of NIR-I light significantly restricts the theranostic efficacy. To address such issue, variety of NIR-II light-mediated phototheranotic systems have been designed and developed (Dai et al., 2021; Yin et al., 2020). Zheng et al. developed a platelet-camouflaged nanoprobe (BLIPO-1048) for tumor active-targeting NIR-II PA imaging-guided PTT (Geng et al., 2020). A commercially available NIR-II-absorbing small molecule dye IR 1048 was first encapsulated by amphiphilic lipid molecules to give IR 1048-loaded liposome (LIPO-1048). The membrane proteins of platelets were then extracted and coated onto the surface of LIPO-1048 via mechanical extrusion treatments to obtain BLIPO-1048. After i. v. Injection of BLIPO-1048 into tumor bearing mice, the nanoprobes could accumulate into tumor site via active targeting owing to the membrane proteins on their surface. Under 1,064 nm laser irradiation, BLIPO-1048 could generate NIR-II PA signal to delineate the tumor site. Meanwhile, the NIR-II photothermal effect of BLIPO-1048 may kill tumor cells (Figure 1A).
FIGURE 1. (A) Schematic illustration of preparation of BLIPO-1048 for NIR-II phototheranostics. (B) Absorption spectra of IR 1048 and BLIPO-1048. (C) NIR-II PA images of BLIPO-1048 under different concentrations. (D) Semiquantitative bioluminescence intensity in the brain of mice. The error bars represent standard deviations of six separate measurements (n = 6). *p < 0.05, **p < 0.01. Adapted from (Geng et al., 2020). Copyright© 2020 American Chemical Society.
BLIPO-1048 had a NIR-II absorption peak at near 1,100 nm, which showed an obvious red-shift compared with IR 1048 (Figure 1B). In addition, the fluorescence intensity of BLIPO-1048 had a 39% decrease compared with IR 1048. These results could be attributed to the aggregation of IR 1048 within BLIPO-1048. Under 1,064 nm laser irradiation, the temperature of BLIPO-1048 solution increased more than 30°C, and its PCE was calculated as 41.17%. Meanwhile, BLIPO-1048 showed strong PA intensity at 1,064 nm. With the increase of concentration, its NIR-II PA intensity increased linearly, demonstrating the feasibility of quantitative study (Figure 1C). By virtue of the membrane protein CD47 on the surface of BLIPO-1048, BLIPO-1048 had a lower uptake by macrophages than LIPO-1048 without cell membrane on the surface. In contrast, BLIPO-1048 showed high tumor cell uptake, which could be attributed to the CD44 protein on its surface. Without laser irradiation, BLIPO-1048 showed good cytocompatibility towards both C6 glioma and bEnd.3 cells. Under 1,064 nm laser irradiation, both LIPO-1048 and BLIPO-1048 showed cytotoxicity against tumor cells. Compared with LIPO-1048 without cell membrane, BLIPO-1048 had a lower IC50 value under 1,064 nm laser irradiation, which could be ascribed to the higher cellular uptake of BLIPO-1048. The in vivo NIR-II PA imaging experiments were conducted by using three different tumor models (pancreatic, breast and glioma tumor model). For all the models, BLIPO-1048 could effectively accumulate into tumor sites and showed stronger NIR-II PA signals than LIPO-1048. In addition, PTT-mediated by BLIPO-1048 showed the highest tumor inhibition rate (85.2%) among all the treatments (Figure 1D). These data indicated that the cell membrane proteins on the surface of BLIPO-1048 may enhance the tumor accumulation of nanoparticles and their PTT efficacy.
As most NIR-II absorbing molecules are hydrophobic, it is necessary to encapsulate them into amphiphilic copolymers via nanoprecipitation method to form water-dispersible nanoparticles (Li and Pu, 2019; Yin et al., 2017). To prepare micelles with highly concentrated hydrophobic cargos, Lovell et al. developed a surfactant stripping method which could effectively remove excess amphiphilic copolymer F127 (Zhang et al., 2016a; Zhang et al., 2016b). By using similar method, they designed a NIR-II absorbing nanoprobe with extremely high concentration for NIR-II PA imaging (Chitgupi et al., 2019). A commercially available NIR-II absorbing dye CyFaP (Figure 2A) was co-loaded with Coenzyme Q10 (CoQ) into F127. To remove the free F127 and empty micelles, the solution was kept at 4°C so that F127 could well dissolved in the water and be removed via ultracentrifugation. After ultracentrifugation, the free F127 was removed from the solution, remaining the micelles with cargos loading. Such process was the so-called “surfactant stripping” which could obtain micelles with high concentration of cargos (Figure 2B). The obtained surfactant-stripped CyFaP micelles (ss-CyFaP) showed a much higher NIR-II absorption compared with CyFaP liposomes prepared by conventional method (Figure 2C). Only less than 5% CyFaP was precipitated after storage for 4 weeks, indicating the superior stability of ss-CyFaP.
FIGURE 2. (A) Chemical structure of CyFaP. (B) Schematic illustration of preparation of surfactant-stripped micelles. (C) Absorption spectra of ss-CyFaP and Liposomal CyFaP. (D) PA overlaid with ultrasound images of tube with water or ss-CyFaP. (E) PA overlaid with ultrasound images of tube with ss-CyFaP under the breast of adult female volunteers. Adapted from (Chitgupi et al., 2019). Copyright© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
The capability of ss-CyFaP for NIR-II PA imaging was evaluated. Even under the coverage of 12 cm chicken breast tissue, the NIR-II PA signal of ss-CyFaP solution could be clearly detected, and its signal-to-noise ratio (SNR) was as high as 24.3 dB. In contrast, no NIR-II PA signal was detected for water under the same condition (Figure 2D). Owing to the high penetration depth, ss-CyFaP was applied for in vivo PA imaging of tumor. Before injection of ss-CyFaP, almost no NIR-II PA signal was observed in the tumor region, while the signal increased significantly after i. v. Injection of ss-CyFaP for 6 h, which showed good tumor accumulation capability of ss-CyFaP. The potential clinical application of ss-CyFaP was demonstrated by imaging of ss-CyFaP through whole human breast. The NIR-II PA signal of ss-CyFaP solution could effectively penetrate 5.1 cm of human breast, indicating the promise of ss-CyFaP in human breast cancer detection (Figure 2E).
In summary, the above two studies showed the promise of small molecule dyes for NIR-II PA imaging and phototherapy. Both BLIPO-1048 and ss-CyFaP had strong NIR-II absorption and their NIR-II PA signals could have a penetration depth up to several centimeters. In addition, they both chose commercially available dyes coated with biocompatible cell membranes or FDA-approved amphiphilic materials, and the preparations of these nanosystems were simple enough. From a biological application point of view, these features made them great promise in clinical translation, which was confirmed by the fact that the NIR-II PA signal of ss-CyFaP could penetrate the whole human breast.
4 NIR-II PA imaging-guided combination therapy
Although phototherapy has shown great promise in the cancer therapy, its therapeutic efficacy is still limited (Torres et al., 2021; Xie et al., 2020a). For example, high temperature may induce the overexpression of heat shock proteins (HSPs) which can alleviate the damage of heat to cancer cells (Gao et al., 2020). On the other hand, photodynamic therapy (PDT) usually requires oxygen to generate reactive oxygen species (ROS) for cancer cell killing. However, the hypoxic environment of solid tumor may not provide enough oxygen (Li et al., 2018b). Thus, more and more studies have developed combination therapeutic nanosystems which combine phototherapy with other therapeutic modalities (Zhao et al., 2020; He et al., 2022). Some inhibitors or chemotherapy drugs were reported to suppress the HSP expression, by introducing them into PTT system, photothermal/chemo combination therapy can be achieved (Gao et al., 2021). HSPs may also be damaged by alkyl radicals (Wang et al., 2022). Thus, combining PTT with thermodynamic therapy can achieve synergistic therapeutic efficacy. In addition, both PTT and PDT are able to trigger immunogenic cell death (ICD) for immunotherapy. Such process is the so-called photo-immunotherapy which is a combination of phototherapy and immunotherapy (Wang et al., 2021). Overall, these additional therapeutic modalities can remedy the disadvantages of phototherapy and provide a better therapeutic efficacy for combination therapeutic system (Li et al., 2019).
Feng et al. designed a surfactant-stripped micelles (HBP/PTX micelles) for NIR-II PA imaging-guided PTT/chemotherapy combination therapy (Zhang et al., 2020). HBP/PTX micelles were prepared by encapsulating a boron-dipyrromethenes (BODIPY) derivative (HBP) and paclitaxel (PTX) into F127, then removing excess F127 via surfactant stripping method (Figure 3A). Such micelles exhibited strong NIR-II absorption at 1,012 nm with NIR-II fluorescence emission. Under 1,064 nm laser irradiation, HBP/PTX micelles showed satisfactory photothermal effect which the solution temperature could increase up to 26 °C. HBP/PTX micelles could light up lymph nodes of mice by their NIR-II fluorescence signal. In addition, such micelles had high tumor accumulation and could delineate tumor tissue via NIR-II fluorescence imaging. HBP/PTX micelles showed strong NIR-II PA signal at 1,064 nm, which could be attributed to the encapsulated HBP molecule in the micelles. Similar with NIR-II fluorescence imaging, the NIR-II PA signal of HBP/PTX micelles could effectively detect the tumor of mice. HBP/PTX micelles also showed good anticancer efficacy. PTT could be induced by 1,064 nm laser irradiation, and the loaded PTX in the micelles was able to kill cancer cells by chemotherapy. Under laser irradiation, HBP/PTX micelles could totally inhibit the tumor growth of mice, showing excellent in vivo anticancer efficacy.
FIGURE 3. (A) Schematic illustration of structures of HBP/PTX micelles and their all-in-one NIR-II phototherapeutics for NIR-II fluorescence/PA imaging-guided PTT and chemotherapy. (B) Schematic illustration of preparation of BDP-Fe NPs and their applications for NIR-II PA imaging-guided PTT and CDT. Adapted from (Zhang et al., 2020; Ou et al., 2020). Copyright© 2020 Elsevier B.V., 2020 Royal Society of Chemistry.
Chemodynamic therapy (CDT) is a kind of novel cancer therapeutic modality which catalyzes H2O2 in the tumor site into highly toxic ROS to kill cancer cells (Tang et al., 2019; Lin et al., 2018). Dong et al. synthesized a BODIPY derivative (BDP-4OH) with two catechol groups (Ou et al., 2020). BDP-4OH could chelate Fe3+ ion by its catechol groups and form three-dimensional compounds (BDP-Fe). After encapsulating such compounds by F127, the Fe-chelated BODIPY nanoparticles (BDP-Fe NPs) were obtained. BDP-Fe NPs could not only apply for NIR-II PA imaging, but also kill cancer cells via PTT/CDT combination therapy (Figure 3B). BDP-Fe NPs had broad absorption spectrum with strong absorption at 1,064 nm. Under neutral pH, BDP-Fe NPs could not catalyze H2O2 into hydroxyl radical. In contrast, hydroxyl radical was generated under pH 5.0 under catalysis of BDP-Fe NPs, triggering the process of CDT. Such result indicated that the CDT process could only be activated under acidic condition. BDP-Fe NPs also exhibited good photothermal effect, the temperature of BDP-Fe NPs solution could increase 23°C under 730 nm laser irradiation. Owing to the effect of PTT and CDT for BDP-Fe NPs, they were applied for in vitro and in vivo anticancer study. Under laser irradiation, the IC50 of HeLa cells could reach as low as 19.4 μg/ml with the treatment of H2O2. The confocal fluorescence imaging indicated that BDP-Fe NPs may increase the intracellular ROS level, showing that CDT process was triggered within HeLa cells. Because of the relatively strong NIR-II absorption, BDP-Fe NPs were applied for NIR-II PA imaging of tumor. After i. v. Injection of BDP-Fe NPs, the NIR-II PA signal in the tumor site increased gradually, demonstrating the accumulation of BDP-Fe NPs in the tumor and the capability of in vivo NIR-II PA imaging of BDP-Fe NPs. Under 730 nm laser, BDP-Fe NPs could effectively inhibit the growth of tumor, proving the anticancer efficacy of PTT/CDT combination therapy induced by BDP-Fe NPs.
Glutathione (GSH) is commonly overexpressed in cancer cells which plays important role in regulating the intracellular ROS level, and depleting GSH may induce ROS-mediated ferroptosis of cancer cells (Sang et al., 2020). Cysteine is a critical precursor in the biosynthesis of GSH. Thus, depletion of cysteine is an effective approach to trigger ferroptosis of cancer cells (Cheng et al., 2019). Dong et al. designed charge-transfer complexes nanoparticles for NIR-II PA imaging-guided PTT and ferroptosis (Ou et al., 2021). TMB could form charge-transfer complexes with TCNQ or F4TCNQ. After encapsulating these complexes with F127 and folic acid-capped PEG, the nanoparticles (TMB-TCNQ and TMB-F4TCNQ) were prepared. Under NIR-II laser irradiation, these nanoparticles exhibited both NIR-II PA signal and photothermal effect. On the other hand, the cyano groups of TCNQ and F4TCNQ could react with cysteine to form adducts which may deplete cysteine within cancer cells to induce ferroptosis (Figure 4A).
FIGURE 4. (A) Schematic illustration of preparation of charge-transfer complex nanoparticles and their applications in NIR-II PA imaging, PTT and ferroptosis. (B) Absorption spectrum change of TMB-F4TCNQ under treatment of cysteine with time at 50°C. (C) Viability of 4T1 or HeLa cells treated with different concentrations of TMB-F4TCNQ under 1,060 nm laser irradiation. (D) NIR-II PA images of tumor region from TMB-F4TCNQ-treated 4T1 tumor-bearing mice at different post-injection time. The error bars represent standard deviations of three separate measurements (n = 3). Adapted from (Ou et al., 2021). Copyright© 2021 Wiley-VCH GmbH.
The ESR spectra demonstrated the formation of charge-transfer complexes between TMB and TCNQ or F4TCNQ. In addition, TMB had a higher charge transfer degree with F4TCNQ than TCNQ (72 vs. 48%) indicated by Raman spectra. Both TMB-TCNQ and TMB-F4TCNQ had strong NIR-II absorption. Under 1,060 nm laser irradiation, the solution temperature of TMB-TCNQ and TMB-F4TCNQ increased over time. Furthermore, TMB-F4TCNQ had a higher temperature increase than TMB-TCNQ (22.4 vs. 17.8°C), indicating the higher PCE of TMB-F4TCNQ. With treatment of cysteine, the absorption of TMB-F4TCNQ in the NIR region decreased with the increase of treatment time under 50 °C, which could be attributed to the reaction between F4TCNQ and cysteine. On the contrary, other antioxidants such as GSH, N-acetyl-l-cysteine (NAC) may not react with TMB-F4TCNQ and change its absorption. TMB-F4TCNQ could be internalized into 4T1 cells, and deplete GSH within cells. Meanwhile, the ROS and malondialdehyde level in 4T1 was elevated under TMB-F4TCNQ treatment, demonstrating that TMB-F4TCNQ could induce ferroptosis of 4T1 cells. Under 1,060 nm laser irradiation, the viability of both 4T1 and HeLa cells decreased with the increase of TMB-F4TCNQ concentration, and the IC50 for 4T1 and HeLa cells were calculated as 23 and 42 μg/ml (Figure 4C). By virtue of its strong NIR-II absorption, TMB-F4TCNQ was applied for in vivo NIR-II PA imaging. After injection, the NIR-II PA signal in tumor region of mice was significantly higher than that before injection, and such signal reached maximum at 4 h post-injection (Figure 4D). On the other hand, the tumor temperature could increase up to 53.6°C within 5 min under laser irradiation for TMB-F4TCNQ-injected mice. In addition, the tumor growth could be totally inhibited after treatment of TMB-F4TCNQ with laser irradiation, proving the anticancer efficacy of photothermal and ferroptosis combination therapy.
In summary, the above studies showed the examples of small molecule dyes for NIR-II PA imaging-guided combination therapy. Anticancer drugs, metal ions and cysteine responsive molecules were need to be introduced into the nanosystems to achieve the capability of combination therapy. Compared with the phototheranostic nanosystems discussed in the previous section, combination therapeutic nanosystems had much more complicated compositions. Although such feature made them still far from clinical translation at this stage, these studies expanded the biological applications of NIR-II PA imaging-based nanotheranostics and provided new horizons for combination therapy.
5 Discussion
We herein summarize recent advances in NIR-II PA imaging-guided phototheranostic nanosystems based on small molecule dyes. Owing to the high tissue penetration depth of NIR-II laser, NIR-II PA imaging has a remarkably high imaging depth and is suitable for tumor diagnosis. Compared with large molecules such as semiconducting polymers, small molecule dyes have relatively shorter metabolic time, which are more promise in the clinical translation. Until now, several small molecule dye-based nanotheranostics have been developed for NIR-II PA imaging-related applications. Cell membrane can be coated onto them to improve their tumor targeting capability for NIR-II PA imaging and PTT. By using surfactant-stripped approach, high concentration nanosystems can be prepared via removing excess F127 for NIR-II PA imaging and imaging-guided photothermal/chemo combination therapy. Besides chemotherapy, other therapeutic modalities including CDT and ferroptosis may be introduced into these nanosystems to further enrich their therapeutic function. These studies demonstrate the feasibility of small molecule dye-based nanosystems for the applications in NIR-II PA imaging and cancer therapy.
As discussed before, the small molecule dye-based NIR-II PA contrast agents can be classified into three types: NIR-II-absorbing molecules, metal complexes and charge-transfer complexes. Although all of them show satisfactory NIR-II PA imaging effect, their potential in such field is different. Metal complexes have very broad absorption spectrum. However, their absorption coefficient in the NIR-II region is relatively low [44] Meanwhile, such complexes are usually 3D networks and cannot be regarded as “small molecule” strictly. Charge-transfer complexes may have very long absorption wavelengths. However, at least two compounds are required to form such complexes via π-π stacking interaction, making them difficult to be prepared. (Ou et al., 2021). In addition, such interactions are readily to be destructed compared with covalent interaction. NIR-II-absorbing molecules are the most promising contrast agents among all these three types. They have strong NIR-II absorption with stable chemical structures. The only issue for NIR-II-absorbing molecules is the photostability, as some of them are cyanine derivatives which part of them are reported to have poor photostability (Zhao et al., 2019). Apart from these three types of agents, D-A-D type oligomers are also promising NIR-II PA contrast agents. They have a much better photostability than cyanine derivatives and are more facile to be synthesized (Yin et al., 2021b), which can be one of the future directions in the development of NIR-II PA contrast agents.
On the other hand, some other aspects can also be improved to promote the applications of these small molecule dyes in cancer theranostics. Until now, most reported small molecule dyes for NIR-II PA imaging are hydrophobic, which need to be transferred into nanoparticles to increase their water solubility for biological applications. Such nanoparticles are mostly micelles and the cargoes within them may suffer from the issue of burst release during circulation (Xie et al., 2017; Xie et al., 2020b). Modifying hydrophobic small molecule dyes with hydrophilic moieties to obtain amphiphilic dyes which can self-assemble in the aqueous solution is a feasible approach to address such issue. On the other hand, although small molecule dyes-formed nanoparticles have relatively faster clearance rate than polymers-based nanoparticles, they are still cleared out of body via hepatobiliary metabolism. Compared with hepatobiliary metabolism, renal clearance is a faster metabolism pathway which can minimized the long-term toxicity of materials (Huang et al., 2019c). Designing water-soluble small molecule dyes with the capability of renal clearance for NIR-II PA imaging may become one of the future directions.
Author contributions
WZ writes the original draft of manuscript; LY, XZ, TL, ZG and YL edit the manuscript; WZ, CX and QF discuss the scope and content of this review; WZ and CX review the final version of the review.
Funding
This work was supported by the National Natural Science Foundation of China (No. 61905122, 22174070), Natural Science Foundation of Jiangsu Province (No. BK20190735), Natural Science Foundation of Jiangsu University (No. 21KJB150022), Natural Science Foundation of NJUPT (No. NY221088), the Research startup fund of NJUPT (No. NY220149, NY219006), and the Synergetic Innovation Center for Organic Electronics and Information Displays for the financial support.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Antaris, A. L., Chen, H., Cheng, K., Sun, Y., Hong, G., Qu, C., et al. (2016). A small-molecule dye for NIR-II imaging. Nat. Mat. 15, 235–242. doi:10.1038/nmat4476
Attia, A. B. E., Balasundaram, G., Moothanchery, M., Dinish, U. S., Bi, R., Ntziachristos, V., et al. (2019). A review of clinical photoacoustic imaging: Current and future trends. Photoacoustics 16, 100144. doi:10.1016/j.pacs.2019.100144
Cai, Y., Si, W., Huang, W., Chen, P., Shao, J., and Dong, X. (2018). Organic dye based nanoparticles for cancer phototheranostics. Small 14, 1704247. doi:10.1002/smll.201704247
Cao, Z., Feng, L., Zhang, G., Wang, J., Shen, S., Li, D., et al. (2018). Semiconducting polymer-based nanoparticles with strong absorbance in NIR-II window for in vivo photothermal therapy and photoacoustic imaging. Biomaterials 155, 103–111. doi:10.1016/j.biomaterials.2017.11.016
Chalati, T., Horcajada, P., Gref, R., Couvreura, P., and Serreb, C. (2011). Optimisation of the synthesis of MOF nanoparticles made of flexible porous iron fumarate MIL-88a. J. Mat. Chem. 21, 2220–2227. doi:10.1039/C0JM03563G
Chen, Q., Chen, J., He, M., Bai, Y., Yan, H., Zeng, N., et al. (2019). Novel small molecular dye-loaded lipid nanoparticles with efficient near-infrared-II absorption for photoacoustic imaging and photothermal therapy of hepatocellular carcinoma. Biomater. Sci. 7, 3165–3177. doi:10.1039/c9bm00528e
Chen, J., Qi, J., Chen, C., Chen, J., Liu, L., Gao, R., et al. (2020a). Tocilizumab-conjugated polymer nanoparticles for NIR-II photoacoustic-imaging-guided therapy of rheumatoid arthritis. Adv. Mat. 32, 2003399. doi:10.1002/adma.202003399
Chen, C., Tian, R., Zeng, Y., Chu, C., and Liu, G. (2020b). Activatable fluorescence probes for "Turn-On" and ratiometric biosensing and bioimaging: From NIR-I to NIR-II. Bioconjug. Chem. 31, 276–292. doi:10.1021/acs.bioconjchem.9b00734
Cheng, T., Huang, W., Gao, D., Yang, Z., Zhang, C., Zhang, H., et al. (2019). Michael addition/S, N-intramolecular rearrangement sequence enables selective fluorescence detection of cysteine and homocysteine. Anal. Chem. 91, 10894–10900. doi:10.1021/acs.analchem.9b02814
Cheng, P., Chen, W., Li, S., He, S., Miao, Q., and Pu, K. (2020). Fluoro-photoacoustic polymeric renal reporter for real-time dual imaging of acute kidney injury. Adv. Mat. 32, 1908530. doi:10.1002/adma.201908530
Chitgupi, U., Nyayapathi, N., Kim, J., Wang, D., Sun, B., Li, C., et al. (2019). Surfactant-Stripped micelles for NIR-II photoacoustic imaging through 12 cm of breast tissue and whole human breasts. Adv. Mat. 31, 1902279. doi:10.1002/adma.201902279
Cui, D., Li, P. C., Zhen, X., Li, J. C., Jiang, Y. Y., Yu, A. X., et al. (2019). Thermoresponsive semiconducting polymer nanoparticles for contrast-enhanced photoacoustic imaging. Adv. Funct. Mat. 29, 1903461. doi:10.1002/adfm.201903461
Dai, Y., Zhao, H., He, K., Du, W., Kong, Y., Wang, Z., et al. (2021). NIR-II excitation phototheranostic nanomedicine for fluorescence/photoacoustic tumor imaging and targeted photothermal-photonic thermodynamic therapy. Small 17, 2102527. doi:10.1002/smll.202102527
Gao, G., Jiang, Y., Guo, Y., Jia, H., Cheng, X., Deng, Y., et al. (2020). Enzyme-mediated tumor starvation and phototherapy enhance mild-temperature photothermal therapy. Adv. Funct. Mat. 30, 1909391. doi:10.1002/adfm.201909391
Gao, G., Sun, X., and Liang, G. (2021). Nanoagent-promoted mild-temperature photothermal therapy for cancer treatment. Adv. Funct. Mat. 31, 2100738. doi:10.1002/adfm.202100738
Geng, X., Gao, D., Hu, D., Liu, Q., Liu, C., Yuan, Z., et al. (2020). Active-targeting NIR-II phototheranostics in multiple tumor models using platelet-camouflaged nanoprobes. ACS Appl. Mat. Interfaces 12, 55624–55637. doi:10.1021/acsami.0c16872
Guo, T., Tang, Q., Guo, Y., Qiu, H., Dai, J., Xing, C., et al. (2021). Boron quantum dots for photoacoustic imaging-guided photothermal therapy. ACS Appl. Mat. Interfaces 13, 306–311. doi:10.1021/acsami.0c21198
Gupta, N., Chan, Y. H., Saha, S., and Liu, M. H. (2021). Near-infrared-II semiconducting polymer dots for deep-tissue fluorescence imaging. Chem. Asian J. 16, 175–184. doi:10.1002/asia.202001348
Huang, J., Li, J., Lyu, Y., Miao, Q., and Pu, K. (2019a). Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury. Nat. Mat. 18, 1133–1143. doi:10.1038/s41563-019-0378-4
Huang, K., Zhang, Y., Lin, J., and Huang, P. (2019b). Nanomaterials for photoacoustic imaging in the second near-infrared window. Biomater. Sci. 7, 472–479. doi:10.1039/c8bm00642c
Huang, J., Xie, C., Zhang, X., Jiang, Y., Li, J., Fan, Q., et al. (2019c). Renal-clearable molecular semiconductor for second near-infrared fluorescence imaging of kidney dysfunction. Angew. Chem. Int. Ed. 58, 15120–15127. doi:10.1002/anie.201909560
Huang, J., and Pu, K. (2020). Activatable molecular probes for second near-infrared fluorescence, chemiluminescence, and photoacoustic imaging. Angew. Chem. Int. Ed. 59, 11717–11731. doi:10.1002/anie.202001783
He, S., Li, J., Lyu, Y., Huang, J., and Pu, K. (2020a). Near-infrared fluorescent macromolecular reporters for real-time imaging and urinalysis of cancer immunotherapy. J. Am. Chem. Soc. 142, 7075–7082. doi:10.1021/jacs.0c00659
He, M., Wu, D., Zhang, Y., Fan, X., Zhuang, S., Yang, W., et al. (2020b). Protein-enhanced NIR-IIb emission of indocyanine green for functional bioimaging. ACS Appl. Bio Mat. 3, 9126–9134. doi:10.1021/acsabm.0c01384
He, S., Liu, J., Zhang, C., Wang, J., and Pu, K. (2022). Semiconducting polymer Nano-regulators with Cascading activation for photodynamic cancer immunotherapy. Angew. Chem. Int. Ed. Engl. 61, 202116669. doi:10.1002/anie.202116669
Hoelen, C. G., de Mul, F. F., Pongers, R., and Dekker, A. (1998). Three-dimensional photoacoustic imaging of blood vessels in tissue. Opt. Lett. 23, 648–650. doi:10.1364/ol.23.000648
Jiang, Y. Y., Upputuri, P. K., Xie, C., Zeng, Z. L., Sharma, A., Zhen, X., et al. (2019). Metabolizable semiconducting polymer nanoparticles for second near-infrared photoacoustic imaging. Adv. Mat. 31, 1808166. doi:10.1002/Adma.201808166
Kim, T., Zhang, Q., Li, J., Zhang, L., and Jokerst, J. V. (2018). A gold/silver hybrid nanoparticle for treatment and photoacoustic imaging of bacterial infection. ACS Nano 12, 5615–5625. doi:10.1021/acsnano.8b01362
Li, Z., Zhang, C., Zhang, X., Sui, J., Jin, L., Lin, L., et al. (2022). NIR-II functional materials for photoacoustic theranostics. Bioconjug. Chem. 33, 67–86. doi:10.1021/acs.bioconjchem.1c00520
Li, Q., Li, S., He, S., Chen, W., Cheng, P., Zhang, Y., et al. (2020). An activatable polymeric reporter for near-infrared fluorescent and photoacoustic imaging of invasive cancer. Angew. Chem. Int. Ed. 59, 7018–7023. doi:10.1002/anie.202000035
Li, J., Cui, D., Jiang, Y., Huang, J., Cheng, P., and Pu, K. (2019). Near-infrared photoactivatable semiconducting polymer nanoblockaders for metastasis-inhibited combination cancer therapy. Adv. Mat. 31, 1905091. doi:10.1002/adma.201905091
Li, J., Zhen, X., Lyu, Y., Jiang, Y., Huang, J., and Pu, K. (2018a). Cell membrane coated semiconducting polymer nanoparticles for enhanced multimodal cancer phototheranostics. ACS Nano 12, 8520–8530. doi:10.1021/acsnano.8b04066
Li, X., Kwon, N., Guo, T., Liu, Z., and Yoon, J. (2018b). Innovative strategies for hypoxic-tumor photodynamic therapy. Angew. Chem. Int. Ed. 57, 11522–11531. doi:10.1002/anie.201805138
Li, J. C., and Pu, K. Y. (2019). Development of organic semiconducting materials for deep-tissue optical imaging, phototherapy and photoactivation. Chem. Soc. Rev. 48, 38–71. doi:10.1039/C8CS00001H
Lin, L. S., Song, J., Song, L., Ke, K., Liu, Y., Zhou, Z., et al. (2018). Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy. Angew. Chem. Int. Ed. 57, 4902–4906. doi:10.1002/anie.201712027
Lv, G., Guo, W., Zhang, W., Zhang, T., Li, S., Chen, S., et al. (2016). Near-infrared emission CuInS/ZnS quantum dots: All-in-One theranostic nanomedicines with intrinsic fluorescence/photoacoustic imaging for tumor phototherapy. ACS Nano 10, 9637–9645. doi:10.1021/acsnano.6b05419
Mallidi, S., Larson, T., Tam, J., Joshi, P. P., Karpiouk, A., Sokolov, K., et al. (2009). Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett. 9, 2825–2831. doi:10.1021/nl802929u
Manwar, R., Kratkiewicz, K., and Avanaki, K. (2020). Overview of ultrasound detection technologies for photoacoustic imaging. Micromachines 11, 692. doi:10.3390/mi11070692
Meng, X., Song, S., Song, X., Zhu, M., Zhao, S., Wu, L., et al. (2015). A tetranuclear copper cluster-based MOF with sulfonate-carboxylate ligands exhibiting high proton conduction properties. Chem. Commun. 51, 8150–8152. doi:10.1039/C5CC01732G
Miao, Q., and Pu, K. (2018). Organic semiconducting agents for deep-tissue molecular imaging: Second near-infrared fluorescence, self-luminescence, and photoacoustics. Adv. Mat. 30, 1801778. doi:10.1002/adma.201801778
Noh, Y. W., Park, H. S., Sung, M. H., and Lim, Y. T. (2011). Enhancement of the photostability and retention time of indocyanine green in sentinel lymph node mapping by anionic polyelectrolytes. Biomaterials 32, 6551–6557. doi:10.1016/j.biomaterials.2011.05.039
Ou, C., Zhang, Y., Ge, W., Zhong, L., Huang, Y., Si, W., et al. (2020). A three-dimensional BODIPY-iron(III) compound with promoted H2O2-response for NIR-II photoacoustic imaging guided chemodynamic/photothermal therapy. Chem. Commun. 56, 6281–6284. doi:10.1039/D0CC01164A
Ou, C., Na, W., Ge, W., Huang, H., Gao, F., Zhong, L., et al. (2021). Biodegradable charge-transfer complexes for glutathione depletion induced ferroptosis and NIR-II photoacoustic imaging guided cancer photothermal therapy. Angew. Chem. Int. Ed. 60, 8157–8163. doi:10.1002/anie.202014852
Penet, M. F., Mikhaylova, M., Li, C., Krishnamachary, B., Glunde, K., Pathak, A. P., et al. (2010). Applications of molecular MRI and optical imaging in cancer. Future Med. Chem. 2, 975–988. doi:10.4155/fmc.10.25
Pu, K., Shuhendler, A. J., Jokerst, J. V., Mei, J., Gambhir, S. S., Bao, Z., et al. (2014). Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice. Nat. Nanotech. 9, 233–239. doi:10.1038/nnano.2013.302
Sang, Y., Cao, F., Li, W., Zhang, L., You, Y., Deng, Q., et al. (2020). Bioinspired construction of a nanozyme-based H2O2 homeostasis disruptor for intensive chemodynamic therapy. J. Am. Chem. Soc. 142, 5177–5183. doi:10.1021/jacs.9b12873
Soni, K. S., Desale, S. S., and Bronich, T. K. (2016). Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation. J. Control. Release 240, 109–126. doi:10.1016/j.jconrel.2015.11.009
Sun, T., Dou, J. H., Liu, S., Wang, X., Zheng, X., Wang, Y., et al. (2018). Second near-infrared conjugated polymer nanoparticles for photoacoustic imaging and photothermal therapy. ACS Appl. Mat. Interfaces 10, 7919–7926. doi:10.1021/acsami.8b01458
Tang, Z., Liu, Y., He, M., and Bu, W. (2019). Chemodynamic therapy: Tumour microenvironment-mediated fenton and fenton-like reactions. Angew. Chem. Int. Ed. 58, 946–956. doi:10.1002/anie.201805664
Torres, A. E., Lyons, A. B., Hamzavi, I. H., and Lim, H. W. (2021). Role of phototherapy in the era of biologics. J. Am. Acad. Dermatol. 84, 479–485. doi:10.1016/j.jaad.2020.04.095
Upputuri, P. K., and Pramanik, M. (2019). Photoacoustic imaging in the second near-infrared window: A review. J. Biomed. Opt. 24, 1–20. doi:10.1117/1.JBO.24.4.040901
Valluru, K. S., and Willmann, J. K. (2016). Clinical photoacoustic imaging of cancer. Ultrasonography 35, 267–280. doi:10.14366/usg.16035
Wan, Y., Lu, G., Wei, W. C., Huang, Y. H., Li, S., Chen, J. X., et al. (2020). Stable organic photosensitizer nanoparticles with absorption peak beyond 800 nanometers and high reactive oxygen species yield for multimodality phototheranostics. ACS Nano 14, 9917–9928. doi:10.1021/acsnano.0c02767
Wang, L. V., and Hu, S. (2012). Photoacoustic tomography: In vivo imaging from organelles to organs. Science 335, 1458–1462. doi:10.1126/science.1216210
Wang, Q., Dai, Y. N., Xu, J. Z., Cai, J., Niu, X. R., Zhang, L., et al. (2019). All-in-One phototheranostics: Single laser triggers NIR-II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy. Adv. Funct. Mat. 29, 1901480. doi:10.1002/adfm.201901480
Wang, W., Zhang, X., Ni, X., Zhou, W., Xie, C., Huang, W., et al. (2022). Semiconducting polymer nanoparticles for NIR-II fluorescence imaging-guided photothermal/thermodynamic combination therapy. Biomater. Sci. 10, 846–853. doi:10.1039/D1BM01646F
Wang, M., Rao, J., Wang, M., Li, X., Liu, K., Naylor, M. F., et al. (2021). Cancer photo-immunotherapy: From bench to bedside. Theranostics 11, 2218–2231. doi:10.7150/thno.53056
Weber, J., Beard, P. C., and Bohndiek, S. E. (2016). Contrast agents for molecular photoacoustic imaging. Nat. Methods 13, 639–650. doi:10.1038/nmeth.3929
Wu, J., You, L., Lan, L., Lee, H. J., Chaudhry, S. T., Li, R., et al. (2017). Semiconducting polymer nanoparticles for centimeters-deep photoacoustic imaging in the second near-infrared window. Adv. Mat. 29, 1703403. doi:10.1002/adma.201703403
Xie, C., Zhen, X., Lei, Q. L., Ni, R., and Pu, K. Y. (2017). Self-assembly of semiconducting polymer amphiphiles for in vivo photoacoustic imaging. Adv. Funct. Mat. 27, 1605397. doi:10.1002/adfm.201605397
Xie, C., Zhou, W., Zeng, Z., Fan, Q., and Pu, K. (2020b). Grafted semiconducting polymer amphiphiles for multimodal optical imaging and combination phototherapy. Chem. Sci. 11, 10553–10570. doi:10.1039/d0sc01721c
Xie, Z., Fan, T., An, J., Choi, W., Duo, Y., Ge, Y., et al. (2020a). Emerging combination strategies with phototherapy in cancer nanomedicine. Chem. Soc. Rev. 49, 8065–8087. doi:10.1039/d0cs00215a
Xu, C., and Pu, K. (2021). Second near-infrared photothermal materials for combinational nanotheranostics. Chem. Soc. Rev. 50, 1111–1137. doi:10.1039/d0cs00664e
Yang, X., Stein, E. W., Ashkenazi, S., and Wang, L. V. (2009). Nanoparticles for photoacoustic imaging. WIREs Nanomed. Nanobiotechnol. 1, 360–368. doi:10.1002/wnan.42
Yin, C., Li, X., Wang, Y., Liang, Y., Zhou, S., Zhao, P., et al. (2021a). Organic semiconducting macromolecular dyes for NIR-II photoacoustic imaging and photothermal therapy. Adv. Funct. Mat. 31, 2104650. doi:10.1002/adfm.202104650
Yin, C., Lu, X., Fan, Q., and Huang, W. (2021b). Organic semiconducting nanomaterials-assisted phototheranostics in near-infrared-II biological window. View 2, 20200070. doi:10.1002/VIW.20200070
Yin, C., Li, X., Wen, G., Yang, B., Zhang, Y., Chen, X., et al. (2020). Organic semiconducting polymer amphiphile for near-infrared-II light-triggered phototheranostics. Biomaterials 232, 119684. doi:10.1016/j.biomaterials.2019.119684
Yin, C., Zhen, X., Fan, Q. L., Huang, W., and Pu, K. Y. (2017). Degradable semiconducting oligomer amphiphile for ratiometric photoacoustic imaging of hypochlorite. ACS Nano 11, 4174–4182. doi:10.1021/acsnano.7b01092
Yu, J., Wang, X. H., Feng, J., Meng, X., Bu, X., Li, Y., et al. (2019). Antimonene nanoflakes: Extraordinary photoacoustic performance for high-contrast imaging of small volume tumors. Adv. Healthc. Mat. 8, 1900378. doi:10.1002/adhm.201900378
Zhang, Y., Zhang, G., Zeng, Z., and Pu, K. (2022). Activatable molecular probes for fluorescence-guided surgery, endoscopy and tissue biopsy. Chem. Soc. Rev. 51, 566–593. doi:10.1039/d1cs00525a
Zhang, Y., He, S., Chen, W., Liu, Y., Zhang, X., Miao, Q., et al. (2021). Activatable polymeric nanoprobe for near-infrared fluorescence and photoacoustic imaging of T lymphocytes. Angew. Chem. Int. Ed. 60, 5921–5927. doi:10.1002/anie.202015116
Zhang, Y., Tao, H., Li, Q., Sheng, W., Xu, Y., Hao, E., et al. (2020). Surfactant-stripped J-aggregates of azaBODIPY derivatives: All-in-One phototheranostics in the second near infrared window. J. Control. Release 326, 256–264. doi:10.1016/j.jconrel.2020.07.017
Zhang, R. P., Xu, Y. L., Zhang, Y., Kim, H. S., Sharma, A., Gao, J., et al. (2019a). Rational design of a multifunctional molecular dye for dual-modal NIR-II/photoacoustic imaging and photothermal therapy. Chem. Sci. 10, 8348–8353. doi:10.1039/c9sc03504d
Zhang, W., Sun, X., Huang, T., Pan, X., Sun, P., Li, J., et al. (2019b). 1300 nm absorption two-acceptor semiconducting polymer nanoparticles for NIR-II photoacoustic imaging system guided NIR-II photothermal therapy. Chem. Commun. 55, 9487–9490. doi:10.1039/c9cc04196f
Zhang, J., Xu, W., Sheng, P., Zhao, G., and Zhu, D. (2017). Organic donor-acceptor complexes as novel organic semiconductors. Acc. Chem. Res. 50, 1654–1662. doi:10.1021/acs.accounts.7b00124
Zhang, Y., Feng, L., Wang, J., Tao, D., Liang, C., Cheng, L., et al. (2018). Surfactant-stripped micelles of near infrared dye and paclitaxel for photoacoustic imaging guided photothermal-chemotherapy. Small 14, 1802991. doi:10.1002/smll.201802991
Zhang, Y., Song, W., Geng, J., Chitgupi, U., Unsal, H., Federizon, J., et al. (2016a). Therapeutic surfactant-stripped frozen micelles. Nat. Commun. 7, 11649. doi:10.1038/ncomms11649
Zhang, Y., Wang, D., Goel, S., Sun, B., Chitgupi, U., Geng, J., et al. (2016b). Surfactant-stripped frozen pheophytin micelles for multimodal gut imaging. Adv. Mat. 28, 8524–8530. doi:10.1002/adma.201602373
Zhao, Y., Wang, J., Zhu, W., Liu, L., and Pei, R. (2021). The modulation effect of charge transfer on photoluminescence in metal-organic frameworks. Nanoscale 13, 4505–4511. doi:10.1039/D0NR07834D
Zhao, J., Zhang, X., Fang, L., Gao, C., Xu, C., and Gou, S. (2020). Iridium(III) complex-derived polymeric micelles with low dark toxicity and strong NIR excitation for phototherapy and chemotherapy. Small 16, 2000363. doi:10.1002/smll.202000363
Zhao, X., Yang, Y., Yu, Y., Guo, S., Wang, W., and Zhu, S. (2019). A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy. Chem. Commun. 55, 13542–13545. doi:10.1039/C9CC06157F
Zhao, J., Zhong, D., and Zhou, S. (2018). NIR-I-to-NIR-II fluorescent nanomaterials for biomedical imaging and cancer therapy. J. Mat. Chem. B 6, 349–365. doi:10.1039/c7tb02573d
Zhen, X., Zhang, J., Huang, J., Xie, C., Miao, Q., and Pu, K. (2018). Macrotheranostic probe with disease-activated near-infrared fluorescence, photoacoustic, and photothermal signals for imaging-guided therapy. Angew. Chem. Int. Ed. 57, 7804–7808. doi:10.1002/anie.201803321
Zhen, X., Pu, K., and Jiang, X. (2021). Photoacoustic imaging and photothermal therapy of semiconducting polymer nanoparticles: Signal amplification and second near-infrared construction. Small 17, 2004723. doi:10.1002/smll.202004723
Keywords: NIR-II photoacoustic imaging, small molecule dye, phototheranostics, combination therapy, tumor imaging
Citation: Zhou W, Yin L, Zhang X, Liang T, Guo Z, Liu Y, Xie C and Fan Q (2022) Recent advances in small molecule dye-based nanotheranostics for NIR-II photoacoustic imaging-guided cancer therapy. Front. Bioeng. Biotechnol. 10:1002006. doi: 10.3389/fbioe.2022.1002006
Received: 24 July 2022; Accepted: 13 September 2022;
Published: 29 September 2022.
Edited by:
Sierin Lim, Nanyang Technological University, SingaporeReviewed by:
Bang-Ping Jiang, Guangxi Normal University, ChinaYijing Liu, Huazhong University of Science and Technology, China
Copyright © 2022 Zhou, Yin, Zhang, Liang, Guo, Liu, Xie and Fan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chen Xie, aWFtY3hpZUBuanVwdC5lZHUuY24=; Quli Fan, aWFtcWxmYW5Abmp1cHQuZWR1LmNu